Oramed Pharmaceuticals ORMP Cash Flow Statement (2010-2026)

NASDAQ ORMP
$4.14 -0.01 (-0.24%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Oramed Pharmaceuticals Quarterly Cash Flow Statement

Periods 63 quarters
Latest Jun 2026

Oramed Pharmaceuticals reported cash from operations of -$0.20M and free cash flow of -$0.20M for the quarter ended Jun 2026, up 94.3% year over year. This cash flow statement covers 63 quarters of results from Nov 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-8.10M-10.71M-11.07M-7.25M-12.26M-3.61M-1.31M-3.28M13.73M1.53M9.20M-19.64M-10.20M-7.64M13.26M48.39M10.01M38.31M78.16M
Depreciation and DepletionDep. & Depletion
0.01M0.01M0.02M0.02M0.02M0.04M0.05M0.05M0.05M0.06M0.05M0.05M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.01M0.02M0.02M0.02M0.04M0.05M0.05M0.05M0.06M0.05M0.05M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Share-based CompensationStock Comp.
1.71M4.03M1.88M3.05M2.55M0.17M1.82M0.85M1.37M1.29M1.23M0.30M1.23M2.19M0.80M0.72M2.28M1.74M1.39M
Deferred Taxes
7.69M-0.01M9.84M21.80M
Gains from Equity InvestmentsGains Equity
Gains from Sales and DivestituresGains Divest
5.82M
Gains from Investment SecuritiesGains Investment
-16.58M7.27M-3.35M14.78M61.16M-158.69M44.85M103.62M
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
-0.38M-0.24M-0.08M-0.12M-0.35M-1.33M0.06M-0.96M-16.33M-3.75M7.61M-6.02M-0.54M0.13M-0.20M0.82M0.08M-0.14M0.27M
Change in Working Capital
Change in Account PayablesChange Payables
-0.10M-3.23M1.73M-0.62M-0.67M2.22M1.55M
Change in Accured ExpensesChange Accured Exp.
0.00M-0.04M-0.29M0.33M0.01M0.00M-2.23M-0.67M2.22M1.55M0.43M-0.19M-3.10M2.67M1.74M0.15M0.88M
Change in Other Operating AssetsOther Assets Change
-0.38M1.15M0.60M-2.79M0.77M0.03M-0.65M-0.11M-0.13M-0.04M0.03M-0.06M0.42M-0.67M-0.15M0.55M1.26M-0.43M-0.93M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.67M-0.96M-0.38M1.25M-0.74M-0.68M-0.68M-0.02M0.05M0.00M0.00M0.02M0.00M-2.06M-0.16M0.49M-0.11M-1.40M0.12M
Other Working Capital ChangesOther WC Changes
-0.29M-2.11M-0.98M-0.01M0.01M-0.02M-0.01M0.09M0.17M0.04M-0.03M0.08M-0.42M-1.39M-0.01M-0.06M-1.37M-0.97M1.05M
Cash from OperationsCash from Ops.
-6.90M-9.13M-8.49M-2.24M-8.06M-5.55M-2.63M-0.69M-1.42M-1.48M2.08M-7.10M-1.91M-3.52M-3.54M-1.63M-0.47M-2.92M-0.20M
Investing Activities
Capital ExpendituresCapex
0.05M0.02M0.12M0.31M0.20M0.02M0.03M0.00M0.00M0.01M0.01M0.00M0.00M0.00M0.01M0.00M
Change in Property, Plant and EquipmentChange in PP&E
-0.05M-0.02M-0.12M-0.31M-0.20M-0.02M-0.03M0.00M0.00M-0.01M-0.01M0.00M0.00M0.00M-0.01M0.00M
Purchase of InvestmentsInvestments Purchased
0.80M100.00M7.00M7.20M40.21M19.00M70.92M1.45M99.55M4.00M38.45M12.00M8.19M0.76M1.68M19.09M12.86M9.23M
Sale and Maturity of InvestmentsInvestments Sold
0.95M7.41M117.38M8.55M51.75M6.00M56.23M25.91M30.00M34.00M94.66M5.50M27.50M32.06M9.48M40.79M17.94M6.30M22.05M
Other Investing ActivitiesOther investing
0.00M0.00M0.00M
Cash from Investing ActivitiesCash from Investing
-99.05M7.36M10.36M1.23M11.26M-13.20M-14.71M-75.12M30.00M30.00M94.66M-34.26M15.42M23.62M-54.85M38.36M-1.68M-19.49M4.31M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
25.00M19.00M30.55M69.20M
Non-Current Debt
-25.00M-19.00M-30.55M-69.20M
Net Debt Issuances and RepaymentsNet Debt Issuance
-25.00M-19.00M-30.55M-69.20M
Change in Capital Stock
Common Stock IssuedStock Issued
0.23M71.18M2.97M0.00M4.42M4.18M2.43M0.00M0.50M
Shares Repurchased
1.19M0.36M4.01M
Net Shares Issued and RepurchasedNet Shares Issued
0.23M71.18M2.97M0.00M4.42M4.18M2.43M0.00M-1.19M0.50M-0.36M-4.01M
Net Equity Issued and RepurchasedNet Equity Issued
0.23M71.18M2.97M0.00M4.42M4.18M2.43M0.00M-1.19M0.50M-0.36M-4.01M
Dividend Payments
Dividends Paid - Common and PrefferdDiv Paid (Total)
10.36M0.08M
Other financing activitiesOther financing
-0.68M-0.11M-1.52M-0.35M
Cash from Financing ActivitiesCash from Financing
60.56M2.29M0.00M4.31M4.18M2.43M74.55M-25.00M-19.00M-30.55M-1.29M-1.20M-0.36M-4.01M-10.36M-1.95M
Additional items
Exchange Rate EffectFX Effect
0.02M-0.02M0.05M0.00M-0.11M-0.04M0.01M-0.03M0.01M0.00M0.00M0.00M0.00M0.00M0.04M0.00M-0.07M0.02M-0.12M
Change in Cash
-45.37M0.51M1.93M3.30M7.27M-16.36M-17.34M-1.30M3.59M9.52M66.18M-42.65M12.32M20.10M-58.72M36.38M-6.23M-32.75M2.04M
Ending Cash Balance
77.25M31.88M27.97M29.89M33.20M40.46M24.10M6.77M5.47M9.06M18.58M84.75M42.10M54.42M74.52M15.80M52.18M45.95M13.20M15.25M
Free Cash FlowFCF
-6.90M-9.17M-8.51M-2.36M-8.37M-5.75M-2.65M-0.73M-1.42M-1.48M2.08M-7.11M-1.92M-3.52M-3.54M-1.63M-0.47M-2.92M-0.20M
Net Cash FlowNCF
-45.39M0.53M1.87M3.30M7.37M-16.32M-17.34M-1.27M3.58M9.52M66.18M-42.65M12.32M20.10M-58.39M36.38M-6.16M-32.77M2.16M
Interest Paid
0.56M0.57M1.75M
Income Taxes PaidTaxes Paid
0.12M0.62M0.17M-0.81M0.31M2.56M0.53M-6.64M6.64M

Oramed Pharmaceuticals Cash Flow Statement API

Pull Oramed Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ORMP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY